SavedAdd your journal

Journals / Archives of Clinical and Experimental Medicine / 2021 / Cilt: 6 - Sayı: 2

Impact of prediabetes on cardiovascular disease risk in patients with acute myocardial infarctions

Akut miyokard enfarktüslü hastalarda prediyabetin kardiyovasküler hastalık riskine etkisi

Özge ÇAKMAK KARAASLAN
Murat Oğuz ÖZİLHAN
Cem ÇÖTELİ
Orhan MADEN
Pages
83–87
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A total of 332 patients with AMI were enrolled; patients were divided into two groups according to their HbA1c levels: non-diabetic group (HbA1c

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Prediabetes is known to be associated with increased cardiovascular diseases (CVD) risk and mortality.
📊
Key Findings & Data:It has been reported that more than 70% of pre-diabetic patients develop Diabetes Mellitus (DM).
💡
Conclusion & Impact:A total of 332 patients with AMI were enrolled; patients were divided into two groups according to their HbA1c levels: non-diabetic group (HbA1c
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Kardiyovasküler Hastalıklar · Miyokard enfarktüsü · Prediyabetik Durum

Abstract

Aim: Prediabetes is known to be associated with increased cardiovascular diseases (CVD) risk and mortality. It has been reported that more than 70% of pre-diabetic patients develop Diabetes Mellitus (DM). In patients with acute myocardial infarction (AMI), diabetes increases a 2 to 4 fold risk of adverse cardiovascular events compared to non-diabetic patients. This morbidity-mortality relationship begins in the progression phase from normal glucose tolerance to diabetes. We evaluated the relationship between the presence of pre-diabetes by using hemoglobin A1c (HbA1c) values and CVD risk in patients presenting with newly diagnosed AMI. Methods: This study was a retrospective, single-centre and we examined consecutive patients who underwent coronary angiography with a diagnosis of AMI at our hospital between March 2019 and September 2020. A total of 332 patients with AMI were enrolled; patients were divided into two groups according to their HbA1c levels: non-diabetic group (HbA1c

Özet

Amaç: Prediyabetin artmış kardiyovasküler hastalıklar (KVH) riski ve mortalite ile ilişkili olduğu bilinmektedir. Prediyabetik hastaların %70'inden fazlasında Diabetes Mellitus (DM) geliştiği bildirilmiştir. Akut miyokard enfarktüsü (AME) olan hastalarda diyabet, diyabetik olmayan hastalara kıyasla istenmeyen kardiyovasküler olay riskini 2-4 kat artırır. Bu morbidite-mortalite ilişkisi normal glukoz toleransından diyabete ilerleme aşamasında başlar. Yeni tanı almış AME ile başvuran hastalarda, hemoglobin A1c (HbA1c) değerleri kullanılarak prediyabet varlığı ile KVH riski arasındaki ilişkiyi değerlendirdik. Yöntemler: Bu çalışma retrospektif, tek merkezli olup, Mart 2019-Eylül 2020 tarihleri arasında ardışık olarak, hastanemizde AME tanısı ile koroner anjiyografi yapılan hastalar incelendi. Toplam 332 AME hastası kaydedildi; hastalar HbA1c düzeylerine göre 2 gruba ayrıldı: diyabetik olmayan grup (HbA1c

🔖

Cite This Article

KARAASLAN, Ö. Ç., ÖZİLHAN, M. O., ÇÖTELİ, C., MADEN, O. (2022). Impact of prediabetes on cardiovascular disease risk in patients with acute myocardial infarctions. Archives of Clinical and Experimental Medicine, Cilt: 6 - Sayı: 2, 83–87. https://ajindex.com/articles/447814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035-87
  2. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Anesthesiology. 2008;109:14-24
  3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-52
  4. Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab. 2000;26:282-6
  5. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Thompson A, Di Angelantonio E, Gao P, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829-41
  6. American Diabetes Association
  7. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:S14-s31
  8. Ceyhan K, Altunkaş F. Prediabetes, becoming the equivalent of coronary artery disease. Turk Kardiyol Dern Ars. 2012;40:458-65
  9. Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009;32:1327-13. Clin Biochem Rev. 2009;30:197-200
  10. Lankisch M, Füth R, Gülker H, Lapp H, Bufe A, Haastert B, et al. Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol. 2008;97:753-9
  11. Vistisen D, Witte DR, Brunner EJ, Kivimäki M, Tabák A, Jørgensen ME, et al. Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study. Diabetes Care. 2018;41:899-906
  12. Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953
  13. Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, et al. Comparative prognostic pe